What does Apotheek Hulsbosch do?

Apotheek Hulsbosch is a logistics company in Hamont-Achel. Private Limited, started on 14 March 2006, 3 establishments.

What is the address of Apotheek Hulsbosch?

The registered office of Apotheek Hulsbosch is located at Michielsplein 15, 3930 Hamont-Achel.

Is Apotheek Hulsbosch still active?

Yes. According to the CBE (30 October 2026) Apotheek Hulsbosch is active, legal situation “Normale toestand”, started on 14 March 2006.

Is Apotheek Hulsbosch registered on Peppol?

Yes, Apotheek Hulsbosch is registered on the Peppol network with ID 0208:0879969548.

What is the enterprise number of Apotheek Hulsbosch?

The enterprise number of Apotheek Hulsbosch is BE0879969548.

When was Apotheek Hulsbosch founded?

Apotheek Hulsbosch was founded on 14 March 2006.

Who are the directors of Apotheek Hulsbosch?

According to the 2026 annual accounts, the directors of Apotheek Hulsbosch are: KRISTIEN HULSBOSCH.

Is Apotheek Hulsbosch a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 14 March 2006; 5 annual accounts filed, latest fiscal year 2026; 1 directors known from the annual account; 3 establishments in the CBE.

How much profit did Apotheek Hulsbosch make in 2026?

Apotheek Hulsbosch posted a profit after taxes of € 1,935,387 in financial year 2026.

What is the revenue of Apotheek Hulsbosch?

In its most recent annual accounts (2026), Apotheek Hulsbosch reported revenue of € 11,551,341.

How much does an employee at Apotheek Hulsbosch earn?

The average wage cost per full-time employee at Apotheek Hulsbosch was € 66,000 in 2026: staff costs of € 1.1 million for 16.7 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Apotheek Hulsbosch have?

According to the 2026 annual accounts, Apotheek Hulsbosch has 16.7 full-time equivalents (FTE).

Apotheek Hulsbosch (Private Limited) - Hamont-Achel

Dossier Apotheek Hulsbosch, printed on 30 October 2026 from databakkes.be/en/0879969548/apotheek-hulsbosch. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 28 % of short-term debt in 2026; threshold 65 %.

Financials

Financial year 2026

Apotheek Hulsbosch from Hamont-Achel, company number BE0879969548, closed financial year 2026 with a result of € 1.9 million after tax. For that financial year Apotheek Hulsbosch recorded revenue of € 11.6 million and equity of € 6.8 million. Compared with financial year 2025, the result moved from € 1.5 million to € 1.9 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 26, 2026.

What it is worth Growing

€ 6.8 million

▲ 26% vs 2025

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 1.9 million

▲ 27% vs 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 759,495

▲ 29% vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 538,511 paid out

28 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2026

Full-time equivalents

16.7

▲ 4.1 vs 2025

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 790,083 in 2026, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 1.1 million

▲ 29% vs 2025

€ 66,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 116,547

▼ 4% vs 2025

Book value of vehicles, furniture and equipment.

Debts at end 2026

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 3.1 million

▼ 19% vs 2025

€ 402,040 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 420,835

▲ 6% vs 2025

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 18 days on average.

Taxes and wages

€ 209,741

▼ 7% vs 2025

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	2026	Change 2025 → 2026
Revenue	-	-	-	€ 11,551,341 Revenue 2026: € 11,551,341 First fiscal year in the series
Gross margin	€ 2,148,113 Gross margin 2023: € 2,148,113 First fiscal year in the series	€ 2,427,948 Gross margin 2024: € 2,427,948 ▲ 13% vs 2023 (€ 2,148,113) Favourable step	€ 3,057,487 Gross margin 2025: € 3,057,487 ▲ 26% vs 2024 (€ 2,427,948) Favourable step	-
Profit after taxes	€ 881,526 Profit after taxes 2023: € 881,526 First fiscal year in the series	€ 1,015,989 Profit after taxes 2024: € 1,015,989 ▲ 15% vs 2023 (€ 881,526) Favourable step	€ 1,518,187 Profit after taxes 2025: € 1,518,187 ▲ 49% vs 2024 (€ 1,015,989) Favourable step	€ 1,935,387 Profit after taxes 2026: € 1,935,387 ▲ 27% vs 2025 (€ 1,518,187) Favourable step	▲ 27%
Equity	€ 3,994,512 Equity 2023: € 3,994,512 First fiscal year in the series	€ 3,890,813 Equity 2024: € 3,890,813 ▼ 3% vs 2023 (€ 3,994,512) Unfavourable step	€ 5,409,000 Equity 2025: € 5,409,000 ▲ 39% vs 2024 (€ 3,890,813) Favourable step	€ 6,805,876 Equity 2026: € 6,805,876 ▲ 26% vs 2025 (€ 5,409,000) Favourable step	▲ 26%
Total debts	€ 6,535,866 Total debts 2023: € 6,535,866 First fiscal year in the series	€ 6,619,699 Total debts 2024: € 6,619,699 ▲ 1% vs 2023 (€ 6,535,866) Unfavourable step	€ 7,843,428 Total debts 2025: € 7,843,428 ▲ 18% vs 2024 (€ 6,619,699) Unfavourable step	€ 7,634,461 Total debts 2026: € 7,634,461 ▼ 3% vs 2025 (€ 7,843,428) Favourable step	▼ 3%
Cash	€ 556,503 Cash 2023: € 556,503 First fiscal year in the series	€ 573,109 Cash 2024: € 573,109 ▲ 3% vs 2023 (€ 556,503) Favourable step	€ 587,936 Cash 2025: € 587,936 ▲ 3% vs 2024 (€ 573,109) Favourable step	€ 759,495 Cash 2026: € 759,495 ▲ 29% vs 2025 (€ 587,936) Favourable step	▲ 29%
Land & buildings	€ 824,830 Land & buildings 2023: € 824,830 First fiscal year in the series	€ 1,832,099 Land & buildings 2024: € 1,832,099 ▲ 122% vs 2023 (€ 824,830) Unchanged	€ 2,431,372 Land & buildings 2025: € 2,431,372 ▲ 33% vs 2024 (€ 1,832,099) Unchanged	€ 3,250,827 Land & buildings 2026: € 3,250,827 ▲ 34% vs 2025 (€ 2,431,372) Unchanged	▲ 34%
Retained profit	€ 3,982,112 Retained profit 2023: € 3,982,112 First fiscal year in the series	€ 3,878,413 Retained profit 2024: € 3,878,413 ▼ 3% vs 2023 (€ 3,982,112) Unfavourable step	€ 5,396,600 Retained profit 2025: € 5,396,600 ▲ 39% vs 2024 (€ 3,878,413) Favourable step	€ 6,793,476 Retained profit 2026: € 6,793,476 ▲ 26% vs 2025 (€ 5,396,600) Favourable step	▲ 26%
Dividend	€ 0 Dividend 2023: € 0 First fiscal year in the series	€ 1,119,687 Dividend 2024: € 1,119,687 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 1,119,687) Unchanged	€ 538,511 Dividend 2026: € 538,511 Unchanged (€ 0) Unchanged
Bank debt	€ 5,115,235 Bank debt 2023: € 5,115,235 First fiscal year in the series	€ 3,505,057 Bank debt 2024: € 3,505,057 ▼ 31% vs 2023 (€ 5,115,235) Favourable step	€ 3,889,210 Bank debt 2025: € 3,889,210 ▲ 11% vs 2024 (€ 3,505,057) Unfavourable step	€ 3,140,769 Bank debt 2026: € 3,140,769 ▼ 19% vs 2025 (€ 3,889,210) Favourable step	▼ 19%
Balance sheet total	€ 10,530,378 Balance sheet total 2023: € 10,530,378 First fiscal year in the series	€ 10,510,512 Balance sheet total 2024: € 10,510,512 Unchanged (€ 10,530,378) Unchanged	€ 13,252,428 Balance sheet total 2025: € 13,252,428 ▲ 26% vs 2024 (€ 10,510,512) Unchanged	€ 14,440,338 Balance sheet total 2026: € 14,440,338 ▲ 9% vs 2025 (€ 13,252,428) Unchanged	▲ 9%
Employees (FTE)	10.9 Employees (FTE) 2023: 10.9 First fiscal year in the series	11.6 Employees (FTE) 2024: 11.6 ▲ 0.7 vs 2023 (10.9) Unchanged	12.6 Employees (FTE) 2025: 12.6 ▲ 1 vs 2024 (11.6) Unchanged	16.7 Employees (FTE) 2026: 16.7 ▲ 4.1 vs 2025 (12.6) Unchanged	▲ 4.1

Key figures of Apotheek Hulsbosch, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.

What happened to Apotheek Hulsbosch?

What happened at Apotheek Hulsbosch in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 26, 2026 New annual accounts for financial year 2026: profit of € 1.9 million (▲ 27% vs 2025). Source: NBB ↗
2023 KRISTIEN HULSBOSCH became a director. NBB
Jan 1, 2011 New establishment in Pelt. KBO
Jan 1, 2007 New establishment in Hamont-Achel. KBO
Apr 21, 2006 New establishment in Hamont-Achel. KBO
Mar 14, 2006 Start of the company according to the CBE. KBO

In short

From € 881,526 profit in 2023 to € 1.9 million profit in 2026.

Paid € 1.5 million in corporate taxes since 2023.

Best year ever: 2026, with € 1.9 million profit.

On average € 242,700 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

KRISTIEN HULSBOSCH

Apotheek Hulsbosch

Apotheek Mees Hamont Hamont 100%

Farmapunt Achel 100%

Farmapunt Maaseik 100%

Apotheek Hulsbosch Kristien 100%

Behind Apotheek Hulsbosch is KRISTIEN HULSBOSCH. It owns 100% of Apotheek Mees Hamont Hamont, 100% of Farmapunt Achel, 100% of Farmapunt Maaseik and 100% of Apotheek Hulsbosch Kristien itself.

Directors

According to the 2026 annual accounts

KRISTIEN HULSBOSCH

Director

Also active at: FARMAPUNT ACHEL, Apotheek Hulsbosch Kristien, Farmapunt Maaseik, APOTHEEK MEES HAMONT

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Michielsplein 15

3930 Hamont-Achel

2.299.405.190

Ringlaan 31

3900 Pelt

Active since 1 January 2011

2.299.405.289

Stationsstraat 25

3930 Hamont-Achel

Active since 1 January 2007

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 8 companies are registered at this address.

All companies at this address →

SLEURS MANAGEMENT

€ 339,323 gross margin · 2025

FARMAPUNT ACHEL same network

€ 291,653 gross margin · 2025

Apotheek Hulsbosch Kristien same network

€ 223,244 gross margin · 2025

Farmapunt Maaseik same network

€ 337,861 gross margin · 2025

Maatschap Norman

+3 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0879.969.548

VAT number

BE 0879.969.548

Registered office

Michielsplein 15, 3930 Hamont-Achel

Names & denominations

Apotheek Hulsbosch

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

14 March 2006

Peppol

Active · Active since 4 Dec 2025

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

Detailhandel in cosmetica en toiletartikelen

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

Apotheek Hulsbosch

Warning lights

Financials

What happened to Apotheek Hulsbosch?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions